4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-21-134772
Director bought 250,000 shares at $20.00 ($5,000,000)
- Director acquired 3,827,224 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
PARMAR KUSH · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-02 | Conversion : show line 1 in the form | +318,616 | 649,771 | I | ||
| 2021-11-02 | Conversion : show line 2 in the form | +2,371,739 | 3,021,510 | I | ||
| 2021-11-02 | Conversion : show line 3 in the form | +564,217 | 564,217 | I | ||
| 2021-11-02 | Conversion : show line 4 in the form | +254,512 | 3,276,022 | I | ||
| 2021-11-02 | Conversion : show line 5 in the form | +318,140 | 882,357 | I | ||
| 2021-11-02 | Purchase : show line 6 in the form | +250,000 | $20.00 | $5,000,000 | 1,132,357 | I |
| Open-market purchases · 250,000 sh · avg $20.00 · $5,000,000 | ||||||
Table II: Derivative
5 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2021-11-02 | Conversion : show line 7 in the form Series Seed Preferred Stock | −318,616 | 318,616 | 0 | I |
| 2021-11-02 | Conversion : show line 8 in the form Series A Preferred Stock | −2,371,739 | 2,371,739 | 0 | I |
| 2021-11-02 | Conversion : show line 9 in the form Series A Preferred Stock | −564,217 | 564,217 | 0 | I |
| 2021-11-02 | Conversion : show line 10 in the form Series B Preferred Stock | −254,512 | 254,512 | 0 | I |
| 2021-11-02 | Conversion : show line 11 in the form Series B Preferred Stock | −318,140 | 318,140 | 0 | I |
Loading xslF345X03/tm2132054-3_4seq1.xml…